Hyuck Jin Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hyuck Jin Lee has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
- Mi Hee Lim
Korea Advanced Institute of Science and Technology (KAIST)
27 shared publications - Namdoo Kim
Department of Chemistry, Kongju National University, 32588 Gongju, Chungcheongnam-do, Republic of Korea
12 shared publications Juhye Kang
Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea
11 shared publicationsGeewoo Nam
9 shared publications- Ayyalusamy Ramamoorthy
Florida State University
7 shared publications - Kyle J. Korshavn
Department of Chemistry, University of Michigan, Ann Arbor, MI 48109, USA
6 shared publications
Latest Publications
- Open Access
- 14 November 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (11) , 1809
Seaweed-Derived Bioactive Compounds Modulating MMP-2 and MMP-9 in Cancer: Redox Mechanisms and Therapeutic Limitations
Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases which play essential roles in extracellular matrix (ECM) remodeling. Among them, MMP-2 and MMP-9 are mainly associated with tumor invasion, angiogenesis, metastasis, and other pathological processes such as fibrosis and inflammation, making them attractive therapeutic targets for cancer treatment. Marine natural products, particularly seaweed-derived bioactive compounds, have attracted increasing attention because of their structural diversity, broad pharmacological activities, and generally favorable biocompatibility. Seaweeds are a rich source of polysaccharides, phenolic compounds, fatty acids, pigments, vitamins, and other metabolites with anti-inflammatory, anti-oxidant, and anti-cancer properties. Growing evidence indicates that several of these compounds could suppress cancer cell proliferation, invasion, migration, and metastasis by regulating the activity and/or expression of MMP-2 and MMP-9 and their associated signaling pathways, including MAPK signaling pathways. This review comprehensively summarizes current evidence on seaweed-derived bioactive compounds as modulators of MMP 2 and MMP-9 with particular emphasis on their effects on enzymatic activity, expression, and MMP-associated signaling pathways. In addition, current limitations, translational challenges, and future perspectives for developing seaweed-derived compounds as potential MMP-targeted strategies for cancer prevention and therapy are discussed.
- 14 November 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (11) , 1809
Open AccessSeaweed-Derived Bioactive Compounds Modulating MMP-2 and MMP-9 in Cancer: Redox Mechanisms and Therapeutic Limitations
Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases which play essential roles in extracellular matrix (ECM) remodeling. Among them, MMP-2 and MMP-9 are mainly associated with tumor invasion, angiogenesis, metastasis, and other pathological processes such as fibrosis and inflammation, making them attractive therapeutic targets for cancer treatment. Marine natural products, particularly seaweed-derived bioactive compounds, have attracted increasing attention because of their structural diversity, broad pharmacological activities, and generally favorable biocompatibility. Seaweeds are a rich source of polysaccharides, phenolic compounds, fatty acids, pigments, vitamins, and other metabolites with anti-inflammatory, anti-oxidant, and anti-cancer properties. Growing evidence indicates that several of these compounds could suppress cancer cell proliferation, invasion, migration, and metastasis by regulating the activity and/or expression of MMP-2 and MMP-9 and their associated signaling pathways, including MAPK signaling pathways. This review comprehensively summarizes current evidence on seaweed-derived bioactive compounds as modulators of MMP 2 and MMP-9 with particular emphasis on their effects on enzymatic activity, expression, and MMP-associated signaling pathways. In addition, current limitations, translational challenges, and future perspectives for developing seaweed-derived compounds as potential MMP-targeted strategies for cancer prevention and therapy are discussed.
- 2 September 2026
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 126 (18) , 10249-10333
Metal Ions and Protein Aggregation: Unraveling Molecular Interactions and Theranostic Prospects in Proteinopathies
Protein aggregation is a pathological process associated with several human diseases termed proteinopathies, including neurodegenerative and metabolic disorders such as Alzheimer’s disease, Parkinson’s disease, type II diabetes, amyotrophic lateral sclerosis, and Huntington’s disease. In these conditions, specific proteins misfold and accumulate into insoluble aggregates, disrupting normal cellular function and contributing to disease progression. Many studies have investigated the molecular mechanisms that underlie the aggregation pathways, the structure of aggregates, such as oligomeric intermediates and fibrils, and their cellular toxicity. Studies have also investigated the effects of cofactors like metals, lipids, other amyloid proteins, and small molecules. Recent research has increasingly emphasized the critical roles of metal ions such as copper (Cu), zinc (Zn), iron (Fe), and manganese (Mn) in amyloid aggregation and toxicity. Alterations in metal ion transport, binding, or redox activity have been linked to the onset and progression of several amyloid-associated diseases. These metal ions can interact directly with amyloidogenic proteins, influencing their structural conformation, aggregation kinetics, and propensity to form toxic oligomers. This review aims to advance our understanding of how the regulation of metal ions within cells and their dysfunction contribute to the accumulation of harmful proteins, which is a key factor in proteinopathies. By examining the interactions between metal ions and key amyloidogenic proteins─including amyloid-β (Aβ), α-synuclein, tau, superoxide dismutase 1 (SOD1), human islet amyloid polypeptide (hIAPP), and insulin─we highlight both common and unique pathways through which metal ions influence protein aggregation. Additionally, this review explores the impact of metal ions on protein clearance mechanisms, such as autophagy and the ubiquitin–proteasome system, as well as emerging theranostic strategies. These include metal chelation therapies, metal-based imaging agents, and multifunctional compounds designed to restore metal balance while preventing aggregation and toxicity. By integrating biochemical, cellular, and therapeutic insights, this review contributes to a deeper understanding of the metallobiology of proteinopathies and supports the development of novel diagnostic and treatment approaches targeting metal–protein interactions.
- 2 September 2026
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 126 (18) , 10249-10333
Metal Ions and Protein Aggregation: Unraveling Molecular Interactions and Theranostic Prospects in Proteinopathies
Protein aggregation is a pathological process associated with several human diseases termed proteinopathies, including neurodegenerative and metabolic disorders such as Alzheimer’s disease, Parkinson’s disease, type II diabetes, amyotrophic lateral sclerosis, and Huntington’s disease. In these conditions, specific proteins misfold and accumulate into insoluble aggregates, disrupting normal cellular function and contributing to disease progression. Many studies have investigated the molecular mechanisms that underlie the aggregation pathways, the structure of aggregates, such as oligomeric intermediates and fibrils, and their cellular toxicity. Studies have also investigated the effects of cofactors like metals, lipids, other amyloid proteins, and small molecules. Recent research has increasingly emphasized the critical roles of metal ions such as copper (Cu), zinc (Zn), iron (Fe), and manganese (Mn) in amyloid aggregation and toxicity. Alterations in metal ion transport, binding, or redox activity have been linked to the onset and progression of several amyloid-associated diseases. These metal ions can interact directly with amyloidogenic proteins, influencing their structural conformation, aggregation kinetics, and propensity to form toxic oligomers. This review aims to advance our understanding of how the regulation of metal ions within cells and their dysfunction contribute to the accumulation of harmful proteins, which is a key factor in proteinopathies. By examining the interactions between metal ions and key amyloidogenic proteins─including amyloid-β (Aβ), α-synuclein, tau, superoxide dismutase 1 (SOD1), human islet amyloid polypeptide (hIAPP), and insulin─we highlight both common and unique pathways through which metal ions influence protein aggregation. Additionally, this review explores the impact of metal ions on protein clearance mechanisms, such as autophagy and the ubiquitin–proteasome system, as well as emerging theranostic strategies. These include metal chelation therapies, metal-based imaging agents, and multifunctional compounds designed to restore metal balance while preventing aggregation and toxicity. By integrating biochemical, cellular, and therapeutic insights, this review contributes to a deeper understanding of the metallobiology of proteinopathies and supports the development of novel diagnostic and treatment approaches targeting metal–protein interactions.
- 7 June 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Education
- Vol. 103 (7) , 3668-3677
Generative AI in Chemical Education: A Bibliometric Perspective
- 7 June 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Education
- Vol. 103 (7) , 3668-3677
Generative AI in Chemical Education: A Bibliometric Perspective
- Open Access
- 7 May 2026
- Published by Wiley in Bulletin of the Korean Chemical Society
- Vol. 47 (6) , 745-755
Vitamins as potent cancer treatments through regulating the activity and expression of MMP ‐2 and MMP ‐9
Matrix metalloproteinases (MMP‐2 and MMP‐9) are key regulators of cancer progression, contributing to tumor invasion, angiogenesis, and metastasis. Despite the development of synthetic inhibitors, their clinical application remains limited due to toxicity and safety concerns. In this study, we investigated the potential of common vitamins, vitamin A (VA), vitamin B 6 (VB), vitamin C (VC), and vitamin D 3 (VD), as regulators of MMP‐2/9 expression and activity in lung (A549) and cervical (HeLa) cancer cells. Immunofluorescence and Western blot analyses revealed that all examined vitamins could reduce MMP‐2 and MMP‐9 expression, with VA, VD, and VB exhibiting pronounced inhibitory effects in both cell lines. VC showed comparatively modest effects, particularly on MMP‐2 expression. Mechanistically, these reductions were associated with the suppression of MAPK signaling pathways, including decreased phosphorylation of JNK and ERK. Enzymatic activity assays demonstrated that VA and VD selectively inhibited MMP‐2 activity in a dose‐dependent manner, whereas no significant inhibition of MMP‐9 activity was observed. Docking simulations suggested that VA could interact with the S1′ pocket of MMP‐2, while VD could bind near the catalytic domain, supporting their inhibitory potential. Collectively, these findings indicate that vitamins, particularly VA, VD, and VB, could regulate both MMP‐2 and MMP‐9 expression and activity through transcriptional and MAPK signaling pathway modulation. This study highlights the potential of vitamins as low‐toxicity therapeutic or adjunct agents for targeting MMP‐mediated cancer progression.
- 7 May 2026
- Published by Wiley in Bulletin of the Korean Chemical Society
- Vol. 47 (6) , 745-755
Open AccessVitamins as potent cancer treatments through regulating the activity and expression of MMP ‐2 and MMP ‐9
Matrix metalloproteinases (MMP‐2 and MMP‐9) are key regulators of cancer progression, contributing to tumor invasion, angiogenesis, and metastasis. Despite the development of synthetic inhibitors, their clinical application remains limited due to toxicity and safety concerns. In this study, we investigated the potential of common vitamins, vitamin A (VA), vitamin B 6 (VB), vitamin C (VC), and vitamin D 3 (VD), as regulators of MMP‐2/9 expression and activity in lung (A549) and cervical (HeLa) cancer cells. Immunofluorescence and Western blot analyses revealed that all examined vitamins could reduce MMP‐2 and MMP‐9 expression, with VA, VD, and VB exhibiting pronounced inhibitory effects in both cell lines. VC showed comparatively modest effects, particularly on MMP‐2 expression. Mechanistically, these reductions were associated with the suppression of MAPK signaling pathways, including decreased phosphorylation of JNK and ERK. Enzymatic activity assays demonstrated that VA and VD selectively inhibited MMP‐2 activity in a dose‐dependent manner, whereas no significant inhibition of MMP‐9 activity was observed. Docking simulations suggested that VA could interact with the S1′ pocket of MMP‐2, while VD could bind near the catalytic domain, supporting their inhibitory potential. Collectively, these findings indicate that vitamins, particularly VA, VD, and VB, could regulate both MMP‐2 and MMP‐9 expression and activity through transcriptional and MAPK signaling pathway modulation. This study highlights the potential of vitamins as low‐toxicity therapeutic or adjunct agents for targeting MMP‐mediated cancer progression.
- Open Access
Recent Advances in Electrocatalytic Ammonia Synthesis: Integrating Electrolyte Effects, Structural Engineering, and Single-Atom Platforms
The pursuit of sustainable ammonia production has accelerated the development of electrocatalytic pathways capable of operating under ambient conditions with renewable electricity. Recent studies have revealed that the efficiency and selectivity of both electrochemical nitrogen reduction reaction (eNRR) and nitrate reduction reaction (eNO3RR) are not governed solely by catalyst composition, but by the synergistic interplay among electrolyte identity, interfacial solvation structure, and catalyst architecture. Hydrated cations such as Li+ profoundly reshape the electric double layer, polarize interfacial water, and lower activation barriers for key proton–electron transfer steps, thereby redefining the electrolyte as an active promoter. Parallel advances in structural engineering, including alloying, heteroatom doping, controlled defect formation, and nanoscale morphological control, have enabled the optimization of intermediate adsorption energies while simultaneously suppressing competing hydrogen evolution. In addition, the emergence of metal–organic-framework (MOF)-derived single-atom catalysts has demonstrated that atomically dispersed transition-metal centers anchored within dynamically adaptable matrices can deliver exceptional Faradaic efficiencies, high turnover rates, and long-term operational durability. These developments highlight a unified strategy in which electrolyte–catalyst coupling, rational structural modification, and atomic-scale design principles converge to enable predictable and high-performance ammonia electrosynthesis. This review integrates mechanistic insights across these domains and outlines future directions for translating molecular-level understanding into scalable technologies for green ammonia production.
Open AccessRecent Advances in Electrocatalytic Ammonia Synthesis: Integrating Electrolyte Effects, Structural Engineering, and Single-Atom Platforms
The pursuit of sustainable ammonia production has accelerated the development of electrocatalytic pathways capable of operating under ambient conditions with renewable electricity. Recent studies have revealed that the efficiency and selectivity of both electrochemical nitrogen reduction reaction (eNRR) and nitrate reduction reaction (eNO3RR) are not governed solely by catalyst composition, but by the synergistic interplay among electrolyte identity, interfacial solvation structure, and catalyst architecture. Hydrated cations such as Li+ profoundly reshape the electric double layer, polarize interfacial water, and lower activation barriers for key proton–electron transfer steps, thereby redefining the electrolyte as an active promoter. Parallel advances in structural engineering, including alloying, heteroatom doping, controlled defect formation, and nanoscale morphological control, have enabled the optimization of intermediate adsorption energies while simultaneously suppressing competing hydrogen evolution. In addition, the emergence of metal–organic-framework (MOF)-derived single-atom catalysts has demonstrated that atomically dispersed transition-metal centers anchored within dynamically adaptable matrices can deliver exceptional Faradaic efficiencies, high turnover rates, and long-term operational durability. These developments highlight a unified strategy in which electrolyte–catalyst coupling, rational structural modification, and atomic-scale design principles converge to enable predictable and high-performance ammonia electrosynthesis. This review integrates mechanistic insights across these domains and outlines future directions for translating molecular-level understanding into scalable technologies for green ammonia production.
- Open Access
- 19 January 2026
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 41 (1) , 2616019
Investigation of exercise-mimetic bioactive molecules as modulators of MMP activity and expression in cancer cells
Matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, are directly involved in the degradation of the extracellular matrix preceding uncontrolled cancer growth and metastasis. For these reasons, MMPs are considered key therapeutic targets in the development of cancer treatments. Acknowledged for its prophylactic effects against various diseases including cancer, physical exercise has been reported to boost the immune system, enhance endogenous defence mechanisms, manage oxidative stress, and regulate MMP. Despite its benefits, patients with compromised capacity for physical activity due to injuries and frailty are often unable to take advantage of them. As a possible solution for this problem, the alternative therapeutic approach of exercise mimetics has been gaining traction through pharmacological interventions. Exercise mimetics are pharmacological agents that partially mimic the molecular and physiological benefits of physical exercise without requiring actual physical activity. Recent studies have indicated that the potential of these compounds may serve as candidates for further investigation in cancer treatment. In this study, the possible anti-cancer and anti-metastatic-related effects of six selected exercise mimetics (i.e., AICAR, Icariin, Berberine, Betaine, GW501516, and Metformin) were investigated by targeting activity and/or expression of MMP-2/9 in in vitro model. These compounds (i) inhibited MMP-2 activity by interacting with the active site and/or allosteric sites, (ii) downregulated MMP-2/9 expression by influencing STAT3 signalling pathways, and (iii) reduced lung cancer cells (A549) viability to varying degrees. Among the exercise mimetics, Icariin and Berberine have relatively stronger effects on both the activity of MMP-2 and the expression of MMP-2/9 in cancer cells. These findings highlight the novel potential of exercise mimetics as targeted cancer therapeutics through the regulation of MMP activity and expression in cancer progression and metastasis.
- 19 January 2026
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 41 (1) , 2616019
Open AccessInvestigation of exercise-mimetic bioactive molecules as modulators of MMP activity and expression in cancer cells
Matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, are directly involved in the degradation of the extracellular matrix preceding uncontrolled cancer growth and metastasis. For these reasons, MMPs are considered key therapeutic targets in the development of cancer treatments. Acknowledged for its prophylactic effects against various diseases including cancer, physical exercise has been reported to boost the immune system, enhance endogenous defence mechanisms, manage oxidative stress, and regulate MMP. Despite its benefits, patients with compromised capacity for physical activity due to injuries and frailty are often unable to take advantage of them. As a possible solution for this problem, the alternative therapeutic approach of exercise mimetics has been gaining traction through pharmacological interventions. Exercise mimetics are pharmacological agents that partially mimic the molecular and physiological benefits of physical exercise without requiring actual physical activity. Recent studies have indicated that the potential of these compounds may serve as candidates for further investigation in cancer treatment. In this study, the possible anti-cancer and anti-metastatic-related effects of six selected exercise mimetics (i.e., AICAR, Icariin, Berberine, Betaine, GW501516, and Metformin) were investigated by targeting activity and/or expression of MMP-2/9 in in vitro model. These compounds (i) inhibited MMP-2 activity by interacting with the active site and/or allosteric sites, (ii) downregulated MMP-2/9 expression by influencing STAT3 signalling pathways, and (iii) reduced lung cancer cells (A549) viability to varying degrees. Among the exercise mimetics, Icariin and Berberine have relatively stronger effects on both the activity of MMP-2 and the expression of MMP-2/9 in cancer cells. These findings highlight the novel potential of exercise mimetics as targeted cancer therapeutics through the regulation of MMP activity and expression in cancer progression and metastasis.
- 30 September 2025
- Published by Institute of Brain-Based Education in Brain, Digital, & Learning
- Vol. 15 (3) , 423-435
A Study on the Perceptions of Pre-service Science Teachers of Educational Volunteer
The purpose of this study is to investigate the experiences and perceptions of educational volunteer among pre-service science teachers. To explore these aspects, a survey was administered to 72 pre-service science teachers enrolled in a teacher education program. The survey examined participation patterns, perceived teaching competencies, and relevance to their major. The findings of this study are as follows: First, pre-service science teachers primarily engaged in volunteer activities during their early undergraduate years, often selecting institutions based on location and available time rather than on major relevance. Second, those who participated in major-related educational volunteer perceived them as more appropriate and meaningful. Third, participants reported improvements in communication, collaboration, student interaction, and prosocial behavior, although their skills in lesson design and planning showed only modest growth. Lastly, educational volunteer also contributed to clarifying their teaching career aspirations. However, participants identified several challenges, such as unstructured program management and limited alignment with academic content. These findings suggest the need for systematically designed, major-related volunteer programs and institutional support to enhance the educational value of volunteer for future science teachers.
- 30 September 2025
- Published by Institute of Brain-Based Education in Brain, Digital, & Learning
- Vol. 15 (3) , 423-435
A Study on the Perceptions of Pre-service Science Teachers of Educational Volunteer
The purpose of this study is to investigate the experiences and perceptions of educational volunteer among pre-service science teachers. To explore these aspects, a survey was administered to 72 pre-service science teachers enrolled in a teacher education program. The survey examined participation patterns, perceived teaching competencies, and relevance to their major. The findings of this study are as follows: First, pre-service science teachers primarily engaged in volunteer activities during their early undergraduate years, often selecting institutions based on location and available time rather than on major relevance. Second, those who participated in major-related educational volunteer perceived them as more appropriate and meaningful. Third, participants reported improvements in communication, collaboration, student interaction, and prosocial behavior, although their skills in lesson design and planning showed only modest growth. Lastly, educational volunteer also contributed to clarifying their teaching career aspirations. However, participants identified several challenges, such as unstructured program management and limited alignment with academic content. These findings suggest the need for systematically designed, major-related volunteer programs and institutional support to enhance the educational value of volunteer for future science teachers.
- 27 June 2025
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 105 (6)
Front Cover
- 17 June 2025
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 105 (6) , e70145
Exploring Flavonoids as Regulators of MMP‐2 and MMP‐9 in Cancer Pathogenesis
Last few decades, extensive research efforts have been dedicated to uncovering novel cancer treatments. Among the most vital targets in this pursuit are matrix metalloproteinases (MMPs), enzymes integral to the progression and spread of cancer. Their role in tumor development and metastasis positions MMPs as key players in cancer pathogenesis, offering promising avenues for therapeutic intervention. Specifically, MMP‐2 and MMP‐9 have emerged as promising targets in cancer treatment based on their critical roles in cell invasion, angiogenesis, immune evasion, and metastasis. Studies indicate the potential of plant‐derived natural products as anticancer agents through the regulation of MMP activity. Among various phytochemicals, flavonoids are reported to exhibit inhibitory activities against MMPs and antioxidant properties that present them as candidates for anticancer molecules. In this study, the potential of flavonoids as anticancer agents was explored by investigating the effects of flavonoids on (i) cancer cell viability and migration, (ii) enzymatic activity and cellular expression of MMP‐2/9, and (iii) the MAPK signaling pathway. Docking simulation data regarding the interactions between MMP‐2/9 and selected flavonoids provide an in‐depth look at the potential mechanisms through which these molecules suppress the enzymatic activities of MMPs. Select flavonoids exhibited notable efficacy in suppressing cell proliferation and migration in A549 cells, which may be a consequence of their ability to attenuate MMP activity and expression through the suppression of the MAPK signaling pathway. These observations demonstrate the prospect of flavonoids as a naturally occurring molecular framework for the development of novel anticancer therapeutics.
- 17 June 2025
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 105 (6) , e70145
Exploring Flavonoids as Regulators of MMP‐2 and MMP‐9 in Cancer Pathogenesis
Last few decades, extensive research efforts have been dedicated to uncovering novel cancer treatments. Among the most vital targets in this pursuit are matrix metalloproteinases (MMPs), enzymes integral to the progression and spread of cancer. Their role in tumor development and metastasis positions MMPs as key players in cancer pathogenesis, offering promising avenues for therapeutic intervention. Specifically, MMP‐2 and MMP‐9 have emerged as promising targets in cancer treatment based on their critical roles in cell invasion, angiogenesis, immune evasion, and metastasis. Studies indicate the potential of plant‐derived natural products as anticancer agents through the regulation of MMP activity. Among various phytochemicals, flavonoids are reported to exhibit inhibitory activities against MMPs and antioxidant properties that present them as candidates for anticancer molecules. In this study, the potential of flavonoids as anticancer agents was explored by investigating the effects of flavonoids on (i) cancer cell viability and migration, (ii) enzymatic activity and cellular expression of MMP‐2/9, and (iii) the MAPK signaling pathway. Docking simulation data regarding the interactions between MMP‐2/9 and selected flavonoids provide an in‐depth look at the potential mechanisms through which these molecules suppress the enzymatic activities of MMPs. Select flavonoids exhibited notable efficacy in suppressing cell proliferation and migration in A549 cells, which may be a consequence of their ability to attenuate MMP activity and expression through the suppression of the MAPK signaling pathway. These observations demonstrate the prospect of flavonoids as a naturally occurring molecular framework for the development of novel anticancer therapeutics.
- 29 May 2025
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 36 (6) , 1247-1256
Light-Controllable PEG Hydrogel Cross-Linked by Reversibly Photodissociable Dimeric Green Fluorescent Protein pdDronpa for Drug Delivery
Hydrogel has been widely studied as a carrier model system for drug delivery. Efficient encapsulation of drug molecules and their controlled release are important factors in the design of hydrogels to control drug release at a desired time and location. In this study, we propose a photoresponsive hydrogel with tunable mechanical properties for drug delivery. The hydrogel was synthesized by cross-linking maleimide-functionalized 4-armed polyethylene glycol (4-armed PEG-Mal) with reversibly photodissociable green fluorescent protein pdDronpa. Transitions in the physical state and/or mechanical strength of the hydrogel occurred rapidly when the cross-linking agent pdDronpa was switched off and on between the monomer and dimer states using 500 and 400 nm illumination, respectively. Optically controlled release of fluorescently labeled insulin was investigated, demonstrating the ability of this hydrogel as a potent drug delivery system.
- 29 May 2025
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 36 (6) , 1247-1256
Light-Controllable PEG Hydrogel Cross-Linked by Reversibly Photodissociable Dimeric Green Fluorescent Protein pdDronpa for Drug Delivery
Hydrogel has been widely studied as a carrier model system for drug delivery. Efficient encapsulation of drug molecules and their controlled release are important factors in the design of hydrogels to control drug release at a desired time and location. In this study, we propose a photoresponsive hydrogel with tunable mechanical properties for drug delivery. The hydrogel was synthesized by cross-linking maleimide-functionalized 4-armed polyethylene glycol (4-armed PEG-Mal) with reversibly photodissociable green fluorescent protein pdDronpa. Transitions in the physical state and/or mechanical strength of the hydrogel occurred rapidly when the cross-linking agent pdDronpa was switched off and on between the monomer and dimer states using 500 and 400 nm illumination, respectively. Optically controlled release of fluorescently labeled insulin was investigated, demonstrating the ability of this hydrogel as a potent drug delivery system.